Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses.
Fennelly D, Schneider J, Spriggs D, Bengala C, Hakes T, Reich L, Barakat R, Curtin J, Moore MA, Hoskins W, et al. Fennelly D, et al. Among authors: bengala c. J Clin Oncol. 1995 May;13(5):1160-6. doi: 10.1200/JCO.1995.13.5.1160. J Clin Oncol. 1995. PMID: 7537799 Clinical Trial.
Paclitaxel plus epirubicin in advanced breast cancer.
Conte PF, Gennari A, Salvadori B, Pazzagli C, Bengala C. Conte PF, et al. Among authors: bengala c. Oncology (Williston Park). 1998 Jan;12(1 Suppl 1):40-4. Oncology (Williston Park). 1998. PMID: 9516603 Free article. Clinical Trial.
New combinations with epirubicin in advanced breast cancer.
Conte P, Gennari A, Landucci E, Guarneri V, Donati S, Salvadori B, Bengala C, Orlandini C. Conte P, et al. Among authors: bengala c. Oncology (Williston Park). 2001 May;15(5 Suppl 7):24-7. Oncology (Williston Park). 2001. PMID: 11396361 Free article. Review.
62 results